Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV25/09/2024 | Chg.-24.1902 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,225.6799EUR | -1.08% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 26/09/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 30/06/2024 | Semi-annual report | 2024 | German | 2,233.87 KB |
| 30/06/2024 | Semi-annual report | 2024 | English | 2,123.71 KB |
| 03/06/2024 | Prospectus | 2024 | English | 3,663.84 KB |
| 03/06/2024 | Prospectus | 2024 | German | 5,520.88 KB |
| 01/03/2024 | PRIIP Key Information Document | 2024 | German | 269.24 KB |
| 31/12/2023 | Account statment | 2023 | English | 5,416.37 KB |
| 31/12/2023 | Account statment | 2023 | German | 4,732.66 KB |
| 02/07/2022 | Key Investor Information | 2022 | German | 363.91 KB |
